Many clinical trial status discrepancies identified between ClinicalTrials.gov and EUCTR
- Details
- Category: Research
Approximately one sixth of clinical trials registered on both ClinicalTrials.gov and the EU Clinical Trials Register (EUCTR) have discrepancies in their completion status, according to a study published March 7, 2018 in the open-access journal PLOS ONE by Jessica Fleminger and Ben Goldacre from the University of Oxford, UK.
Drug-producing bacteria possible with synthetic biology breakthrough
- Details
- Category: Research
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles, from the University of Warwick and the University of Surrey. Led by the Warwick Integrative Synthetic Biology Centre at Warwick's School of Engineering and the Faculty of Health and Medical Sciences at the University of Surrey, new research has discovered how to dynamically manage the allocation of essential resources inside engineered cells -
Potential new approach to the treatment of multiple sclerosis
- Details
- Category: Research
A prospective new method of treating patients with multiple sclerosis has been proposed by researchers of the Mainz University Medical Center working in cooperation with researchers of the University of Montreal. In model trials and experiments employing human endothelial cells, they discovered that the EGFL7 protein hinders the migration of immune cells into the central nervous system by stabilizing the blood-brain barrier.
Unique pancreatic stem cells have potential to regenerate beta cells, respond to glucose
- Details
- Category: Research
Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells. These significant findings, published in Cell Reports, open the door to developing regenerative cell therapies for those living with type 1 diabetes, addressing a major challenge that stands in the way of discovering a biological cure for the disease.
New research looks to reduce side effects in commonly used drugs
- Details
- Category: Research
New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anaesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects. One in five Australians experience chronic pain, and 250,000 Australians live with epilepsy, 40 per cent of which are children.
New link between gut bacteria and obesity
- Details
- Category: Research
Researchers at Lund University in Sweden have discovered a new link between gut bacteria and obesity. They found that certain amino acids in our blood can be connected to both obesity and the composition of the gut microbiome. We know less about the significance of our gut bacteria than what many books and magazines on the subject seem to suggest. A lot of the research on the topic is based on animal studies which cannot be directly applied to humans.
Fertility study finds hormone that could support early pregnancy
- Details
- Category: Research
Scientists have identified a hormone that could help prepare the womb lining for pregnancy, research shows. The hormone helps prime cells for implantation, a vital stage in early pregnancy when a fertilised egg attaches to the womb lining, the study suggests. The discovery - made by testing tissue from women aged in their forties - could help scientists develop ways to improve fertility.
More Pharma News ...
- Study weighs risks and benefits of phase I trials in pediatric cancer
- Calcium may play a role in the development of Parkinson's disease
- Women who clean at home or work face increased lung function decline
- Researchers find existing drug effective at preventing onset of type 1 diabetes
- Palm oil in your Valentine's chocolate?
- Light-activated cancer drugs without toxic side effects: fresh insight
- Using injectable self-assembled nanomaterials for sustained delivery of drugs